Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

February 2005

ā€œFrankenstein the Tumorā€ is No More

Commentary and Opinion by R. Lewis Dark /

HOW MANY OF YOU HEARD ABOUT THE TUMOR NAMED ā€œFRANKENSTEINā€? This is a story which made national news in mid-January and again in early February. The story line is simple. A nine-year old boy in Richmond, Virginia was diagnosed in May 2003 with embryonal rhabdomyosarcoma. A grapefruit-sized tumor was impinging on his optic nerves and […]

To access this post, you must purchase The Dark Report.

ā€œFrankenstein the Tumorā€ is No More Read More Ā»

Five Lab Acquisitions Over the Past Ten Weeks

Clinical Laboratory Trends /

CEO SUMMARY: Many lab executives and pathologists will be surprised to learn that five independent laboratory companies were acquired between December 1, 2004 and February 11, 2005. Only one acquisition was announced to the public. The other four were private sales and both buyers and sellers preferred to avoid any publicity associated with these acquisitions.

To access this post, you must purchase The Dark Report.

Five Lab Acquisitions Over the Past Ten Weeks Read More Ā»

Review of 2004 Lab Sales Identifies Buyer Interest

Clinical Laboratory Trends /

CEO SUMMARY: Laboratory acquisition activity was surprisingly high during 2004. One reason is that new buyers appeared in the marketplace. However, all buyers have specific acquisition criteria. When a selling lab meets that criteria, it can expect multiple bidders and a strong purchase price. Hereā€™s a review of 2004ā€™s lab acquisition activity, with commentary about

To access this post, you must purchase The Dark Report.

Review of 2004 Lab Sales Identifies Buyer Interest Read More Ā»

Barristers Offer Insights Into OIG Opinion 04-17

Anatomic Pathology /

CEO SUMMARY: This is an intelligence briefing which tries to ā€œread between the linesā€ and: 1) provide useful information about the OIGā€™s ā€œundeclaredā€ views on physician self-referral issues, particularly as they relate to anatomic pathology condominiums; and, 2) how specialist physician groups and pathologists are reacting to such issues in the real world of the

To access this post, you must purchase The Dark Report.

Barristers Offer Insights Into OIG Opinion 04-17 Read More Ā»

Doctor ā€œPay to Performā€ Launched by Medicare

Laboratory Billing /

CEO SUMMARY: Medicareā€™s just-announced physician ā€œpay-for-performanceā€ program will be a positive development for laboratories and pathologists. One consequence is that physicians will be measured on how effectively they use recommended lab tests in certain areas of care. This will give physicians a motive to work with laboratories which offer added-value lab testing services. HEALTHCAREā€™S 800-POUND

To access this post, you must purchase The Dark Report.

Doctor ā€œPay to Performā€ Launched by Medicare Read More Ā»

Evolution in Pap Marketplace Shows Impact of New Guidelines

Molecular Diagnostics /

NEW GUIDELINES for cervical cancer screening issued last year are fueling strong growth in the sales of Digene Corporationā€™s HPV test. For its fiscal second quarter that ended on December 31, 2004, Digene reported sales of $27.0 million. Thatā€™s a 28% increase from Digeneā€™s sales of $21.1 million for its second quarter last year. HPV

To access this post, you must purchase The Dark Report.

Evolution in Pap Marketplace Shows Impact of New Guidelines Read More Ā»

RFID, Georgetown University Hospital, HIV Screening Studies, MDS, Duke, HCA, Cigna

Clinical Laboratory Trends /

PFIZER AND GLAXO-SK TO USE RFID TAGS IN 2005, RFID TEST IN BLOOD BANK RADIO FREQUENCY IDENTIFICATION (RFID) is making swift progress in a variety of healthcare applications. The Food and Drug Administration (FDA) wants to secure the nationā€™s drug supply through widespread use of RFID tags by 2007. To counter drug counterfeiting, some pharmaceutical

To access this post, you must purchase The Dark Report.

RFID, Georgetown University Hospital, HIV Screening Studies, MDS, Duke, HCA, Cigna Read More Ā»

“February 14, 2005 Intelligence: Late Breaking Lab News”

Late Breaking Lab News /

Thereā€™s a new leader at the Clinical Laboratory Management Association (CLMA). On February 7, 2005, CLMA President Judy Lien announced that the associationā€™s new Chief Executive Officer is Dana Procsal, Ph.D., a veteran laboratory industry executive. Most recently, Procsal was Vice President of Laboratory Improvement Programs at the College of American Pathologists, a position he

To access this post, you must purchase The Dark Report.

“February 14, 2005 Intelligence: Late Breaking Lab News” Read More Ā»

Facebook-f Twitter Linkedin-in

The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com

Ā© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group

;